Send me a link:

*Text messaging rates may apply.

 Dow Down 0.90% Nasdaq Down 1.35%

More On PBMD

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Prima Biomed Ltd. (PBMD)

-NasdaqGM
1.09 Down 0.03(2.68%) 10:45AM EDT - Nasdaq Real Time Price
Prev Close:1.12
Open:1.09
Bid:1.10 x 1500
Ask:1.13 x 200
1y Target Est:N/A
Beta:3.34
Next Earnings Date:N/A
Day's Range:1.09 - 1.11
52wk Range:0.82 - 3.29
Volume:15,479
Avg Vol (3m):86,984
Market Cap:44.64M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PBMD

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia. Its lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human cl... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback